UGT1A6 showed high expression in 13 cancer types (BLCA, CESC, CHOL, COAD, ESCA, HNSC, KIRC, KIRP, LIHC, LUSC, PAAD, READ, STAD) (Figure 2) that are derived from a variety of tissues, including many drug-metabolizing tissues (e.g., liver, kidney, gut). Here, UGT1A6 is linked to cancer.